Free Trial
→ Read this warning immediately (From Porter & Company) (Ad)tc pixel Free THMO Stock Alerts

ThermoGenesis (THMO) Competitors

ThermoGenesis logo
Compare

THMO vs. TBIO, HTGMQ, OLITW, PRENW, and QSIAW

Should you buy ThermoGenesis stock or one of its competitors? MarketBeat compares ThermoGenesis with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with ThermoGenesis include Telesis Bio (TBIO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), and Quantum-Si (QSIAW). These companies are all part of the "measuring and control equipment" industry.

How does ThermoGenesis compare to Telesis Bio?

Telesis Bio (NASDAQ:TBIO) and ThermoGenesis (NASDAQ:THMO) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, media sentiment, risk, profitability, analyst recommendations and valuation.

ThermoGenesis has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%.

Company Net Margins Return on Equity Return on Assets
Telesis Bio-336.59% N/A -61.89%
ThermoGenesis N/A N/A N/A

Telesis Bio has a beta of 2.29, meaning that its stock price is 129% more volatile than the broader market. Comparatively, ThermoGenesis has a beta of 1.1, meaning that its stock price is 10% more volatile than the broader market.

37.6% of Telesis Bio shares are held by institutional investors. Comparatively, 5.8% of ThermoGenesis shares are held by institutional investors. 24.5% of Telesis Bio shares are held by insiders. Comparatively, 78.0% of ThermoGenesis shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Telesis Bio's average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score.

Company Overall Sentiment
Telesis Bio Neutral
ThermoGenesis Neutral

ThermoGenesis has lower revenue, but higher earnings than Telesis Bio. Telesis Bio is trading at a lower price-to-earnings ratio than ThermoGenesis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Telesis Bio$225.09M0.00-$47.72M-$20.52N/A
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A

Summary

ThermoGenesis beats Telesis Bio on 6 of the 9 factors compared between the two stocks.

How does ThermoGenesis compare to HTG Molecular Diagnostics?

ThermoGenesis (NASDAQ:THMO) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk.

ThermoGenesis has higher revenue and earnings than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A

Company Net Margins Return on Equity Return on Assets
ThermoGenesisN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

5.8% of ThermoGenesis shares are held by institutional investors. 78.0% of ThermoGenesis shares are held by insiders. Comparatively, 2.6% of HTG Molecular Diagnostics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, ThermoGenesis' average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score.

Company Overall Sentiment
ThermoGenesis Neutral
HTG Molecular Diagnostics Neutral

ThermoGenesis has a beta of 1.1, meaning that its share price is 10% more volatile than the broader market. Comparatively, HTG Molecular Diagnostics has a beta of 3.25, meaning that its share price is 225% more volatile than the broader market.

Summary

ThermoGenesis beats HTG Molecular Diagnostics on 5 of the 7 factors compared between the two stocks.

How does ThermoGenesis compare to OmniLit Acquisition?

ThermoGenesis (NASDAQ:THMO) and OmniLit Acquisition (NASDAQ:OLITW) are both measuring and control equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, media sentiment, valuation, dividends and analyst recommendations.

OmniLit Acquisition has lower revenue, but higher earnings than ThermoGenesis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A
OmniLit AcquisitionN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
ThermoGenesisN/A N/A N/A
OmniLit Acquisition N/A N/A N/A

In the previous week, ThermoGenesis' average media sentiment score of 0.00 equaled OmniLit Acquisition'saverage media sentiment score.

Company Overall Sentiment
ThermoGenesis Neutral
OmniLit Acquisition Neutral

5.8% of ThermoGenesis shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

ThermoGenesis beats OmniLit Acquisition on 3 of the 3 factors compared between the two stocks.

How does ThermoGenesis compare to Prenetics Global?

Prenetics Global (NASDAQ:PRENW) and ThermoGenesis (NASDAQ:THMO) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, media sentiment, risk, valuation, profitability, analyst recommendations and institutional ownership.

Company Net Margins Return on Equity Return on Assets
Prenetics GlobalN/A N/A N/A
ThermoGenesis N/A N/A N/A

5.8% of ThermoGenesis shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Prenetics Global has higher revenue and earnings than ThermoGenesis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Prenetics Global$92.39MN/AN/AN/AN/A
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A

In the previous week, Prenetics Global's average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score.

Company Overall Sentiment
Prenetics Global Neutral
ThermoGenesis Neutral

Summary

ThermoGenesis beats Prenetics Global on 2 of the 3 factors compared between the two stocks.

How does ThermoGenesis compare to Quantum-Si?

ThermoGenesis (NASDAQ:THMO) and Quantum-Si (NASDAQ:QSIAW) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, earnings, risk and institutional ownership.

Company Net Margins Return on Equity Return on Assets
ThermoGenesisN/A N/A N/A
Quantum-Si N/A N/A N/A

Quantum-Si has lower revenue, but higher earnings than ThermoGenesis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A
Quantum-Si$1.85MN/AN/AN/AN/A

In the previous week, ThermoGenesis' average media sentiment score of 0.00 equaled Quantum-Si'saverage media sentiment score.

Company Overall Sentiment
ThermoGenesis Neutral
Quantum-Si Neutral

5.8% of ThermoGenesis shares are held by institutional investors. 78.0% of ThermoGenesis shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

ThermoGenesis beats Quantum-Si on 3 of the 3 factors compared between the two stocks.

Get ThermoGenesis News Delivered to You Automatically

Sign up to receive the latest news and ratings for THMO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding THMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

THMO vs. The Competition

Export
MetricThermoGenesisLaboratory apparatus & furniture IndustryMedical SectorNASDAQ Exchange
Market Cap$1K$1K$6.40B$12.44B
Dividend YieldN/AN/A2.76%5.28%
P/E Ratio0.00N/A20.9925.77
Price / SalesN/A0.00556.7187.38
Price / CashN/AN/A43.4956.67
Price / BookN/AN/A10.387.20
Net Income-$17.98M-$17.98M$3.57B$335.78M

ThermoGenesis Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
THMO
ThermoGenesis
N/AN/AN/AN/A$1K$9.61MN/A40
TBIO
Telesis Bio
N/A$0.00
flat		N/AN/A$2K$225.09MN/A200
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/A$0.00$6.37MN/A90
OLITW
OmniLit Acquisition
N/A$1.15
+16.2%		N/A+2,306.9%$0.00N/AN/A3
PRENW
Prenetics Global
N/A$0.02
-0.6%		N/A+6.2%$0.00$92.39MN/A1

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:THMO) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners
Opportunity Forming in a U.S. Supply-Chain Weak Spot?
America has a supply-chain problem with graphite - demand is climbing while dependence on foreign sources rema...
i2i Marketing Group, LLC | Sponsoredtc pixel
Trump Is Eyeing the Biggest Monetary Shift Since Nixon
On August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that ni...
Americas Gold Company | Sponsoredtc pixel
The SpaceX supplier that shipped 5 billion chips to Starlink
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
Goldman Sachs just told you what to buy (most people missed it)
Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...
Behind the Markets | Sponsoredtc pixel
Your book attached
Bill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...
Profits Run | Sponsoredtc pixel
I was right about SpaceX
Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...
Brownstone Research | Sponsoredtc pixel